• Profile
Close

Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome) - Results from the European phase 3 open-label safety trial

Neurogastroenterology & Motility Apr 13, 2018

Tack J, et al. - Authors scrutinized the long-term safety of acotiamide and explore the efficacy of acotiamide on postprandial distress syndrome (PDS) symptoms using the validated LPDS, quality of life using SF-36 and SF-NDI, and work productivity using WPAI. Acotiamide demonstrated a change in severity larger than the minimum clinically important difference at weeks 1 and 2 for postprandial fullness and early satiation (meal-related symptoms). An improvement was noted in the quality of life and work productivity from the first measurement (at week 12) up to 1 year. Results affirmed the long-term safety of acotiamide treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay